How can you Best Use Network Analytics and Modelling To Support Digital Engineering In Pharma Manufacturing Operations


01st February 2021 | 10:00 am EST | Presented by Gareth Alford, Lead Engineer at GSK and Bob Lenich, Director of Life Sciences Business at Emerson |BOOK FREE SEAT FOR THIS WEBINAR

Using the development of continuous manufacturing modules as a platform to look at the opportunities that arise through digitalization. The modular continuous manufacturing approach has allowed the detailed development of reproducible digital assets. These have in turn allowed the development of process models, mechanistic and statistical, to sit along side the process development through to manufacturing. The discussion today will look at discussing the challenges, both technical and cultural, and the opportunities that exist both now, and down the line as we build upon the experiences. We will concentrate on the benefits associated with the continuous platform, although the approach is applicable in a wider context, albeit with different technical challenges. Some areas that we will look to explore through the discussions will include the use of the models as part of regulatory filing, the use of the platform as an open source engineering set to build adoption, and how digitalization of our process understanding changes the fabric of the facilities that we operate.

Presented by Gareth Alford, Lead Engineer at GSK

I am a Chartered Chemical Engineer and started my industrial career in 1999 for a Contract Engineering firm; designing building pharmaceutical and Oil and Gas facilities. In 2002 I joined GSK at their R&D facility in Stevenage, as Process Engineer within the Pilot Plant network.

In 2008, I became the lead engineer in primary continuous manufacturing, designing and operating Continuous Processing units in GSK Stevenage; engineering several Pilot, Lab and Manufacturing Flow Facilities.

From 2014 to 2018 I was part of a group called Advanced Manufacturing Technologies, responsible for industrializing continuous manufacturing, and the associated modularization and digitalization opportunities to support rapid deployment of the new technology platforms.

I now am part of a team within R&D responsible for Technology Development for Manufacturing Platforms in GSK, working hard to develop Smart, Small, Agile Factories and make them a reality.

Followed by Bob Lenich, Director of Life Sciences Business at Emerson

Bob is a life-long learner who stays engaged in new technology and organizational trends in order to adapt them to solving operating issues across the process industries. He works with a wide variety of organizations to identify operational problems, evaluate how to make improvements, and then justify and sell the approach. Bob loves seeing the successful deployment of a solution and then sharing the benefits so that others can take advantage of the approach. Bob gets special gratification from seeing how those improvements help areas like Life Science manufacturing improve people’s lives.

Bob currently is responsible for planning Emerson’s strategy for growing our automation business in the Life Science industry globally. He then collaboratively works across the various business units in Emerson to implement the strategy and build the business.
Bob has a BS in Chemical Engineering from Rose Hulman Institute of Technology and an MBA from the University of Texas.

Sponsored by Emerson

 

Life Sciences manufacturers strive to create innovative and reliable products that help people lead healthier lives. Emerson has the automation expertise and technology to solve your greatest cGMP manufacturing challenges and create effective solutions for improving your data management, real-time product quality, reliability, and operating costs. From design to implementation and startup to on-going optimization, rely on Emerson to stay competitive in a global economy.


We will not sell your information to a third party. See our Privacy Policy